BAX
NYSE · Health Care
Baxter International Inc
$17.99
+0.50 (+2.86%)
Financial Highlights (FY 2026)
Revenue
10.98B
Net Income
-934,284,915
Gross Margin
30.7%
Profit Margin
-8.5%
Rev Growth
-9.4%
D/E Ratio
1.55
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 30.7% | 30.7% | 38.6% | 38.6% |
| Operating Margin | -2.6% | -2.4% | 16.0% | 16.1% |
| Profit Margin | -8.5% | -8.1% | 14.3% | 13.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 10.98B | 12.11B | 2.04B | 1.68B |
| Gross Profit | 3.37B | 3.72B | 788.12M | 646.11M |
| Operating Income | -289,795,017 | -287,844,073 | 327.68M | 270.40M |
| Net Income | -934,284,915 | -927,995,169 | 292.17M | 225.22M |
| Gross Margin | 30.7% | 30.7% | 38.6% | 38.6% |
| Operating Margin | -2.6% | -2.4% | 16.0% | 16.1% |
| Profit Margin | -8.5% | -8.1% | 14.3% | 13.4% |
| Rev Growth | -9.4% | -9.4% | -9.5% | +16.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 2.74B | 2.74B | 1.80B | 1.57B |
| Total Equity | 1.77B | 1.77B | 8.50B | 9.00B |
| D/E Ratio | 1.55 | 1.55 | 0.21 | 0.17 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -38,062,532 | -39,906,638 | 449.30M | 354.24M |
| Free Cash Flow | — | — | 327.48M | 250.66M |